|
US6750325B1
(en)
|
1989-12-21 |
2004-06-15 |
Celltech R&D Limited |
CD3 specific recombinant antibody
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US7381803B1
(en)
|
1992-03-27 |
2008-06-03 |
Pdl Biopharma, Inc. |
Humanized antibodies against CD3
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
CZ302070B6
(cs)
|
1998-04-21 |
2010-09-29 |
Micromet Ag |
Jednoretezcový multifunkcní polypeptid, polynukleotid, vektor obsahující tento polynukleotid, bunka transfekovaná tímto polynukleotidem, prostredek obsahující tento polypeptid, polynukleotid nebo vektor a jejich použití a zpusob identifikace aktiváto
|
|
AU2003264009A1
(en)
|
2002-08-15 |
2004-03-03 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
|
JP3803790B2
(ja)
|
2003-02-17 |
2006-08-02 |
株式会社東北テクノアーチ |
新規なダイアボディ型二重特異性抗体
|
|
EP1651659A4
(en)
|
2003-08-07 |
2008-09-17 |
Epitomics Inc |
METHOD FOR HUMANIZATION OF MONOCLONAL RABBIT ANTIBODIES
|
|
DE602004030811D1
(de)
|
2003-10-16 |
2011-02-10 |
Micromet Ag |
Multispezifische deimmunisierte cd3-bindende moleküle
|
|
JP5139800B2
(ja)
|
2004-06-03 |
2013-02-06 |
ノビミューン エスアー |
抗ｃｄ３抗体およびその使用方法
|
|
WO2007101661A1
(en)
|
2006-03-09 |
2007-09-13 |
F.Hoffmann-La Roche Ag |
Anti-drug antibody assay
|
|
US20100015142A1
(en)
|
2006-12-21 |
2010-01-21 |
Macrogenics Inc. |
Methods for the treatment of lada and other adult- onset autoimmune using immunosuppressive monoclonal antibodies with reduced toxicity
|
|
IN2009DN05758A
(https=)
|
2007-03-12 |
2015-07-24 |
Esbatech Ag |
|
|
RS53008B2
(sr)
|
2007-04-03 |
2022-12-30 |
Amgen Res Munich Gmbh |
Interspecijski specifičan cd3-epsilon vezujući domen
|
|
KR20170036814A
(ko)
|
2007-05-21 |
2017-04-03 |
앨더바이오 홀딩스 엘엘씨 |
신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
|
|
KR101530723B1
(ko)
|
2007-06-25 |
2015-06-22 |
에스바테크 - 어 노바티스 컴파니 엘엘씨 |
단일 쇄 항체의 서열에 기초한 공학처리 및 최적화
|
|
US20090074780A1
(en)
|
2007-06-25 |
2009-03-19 |
David Urech |
Methods of modifying antibodies, and modified antibodies with improved functional properties
|
|
CN104004094B
(zh)
|
2008-06-25 |
2017-09-22 |
艾斯巴技术-诺华有限责任公司 |
使用通用抗体构架进行的兔抗体的人源化
|
|
PL3241843T3
(pl)
|
2008-06-25 |
2021-12-27 |
Novartis Ag |
Optymalizacja rozpuszczalności cząsteczek immunowiążących
|
|
CA2898100C
(en)
|
2013-01-14 |
2023-10-10 |
Xencor, Inc. |
Novel heterodimeric proteins
|
|
CA2902739C
(en)
|
2013-03-15 |
2022-11-22 |
Xencor, Inc. |
Heterodimeric proteins
|
|
UA129760C2
(uk)
|
2013-12-17 |
2025-07-30 |
Дженентек, Інк. |
Анти-cd3 антитіло та спосіб його застосування
|
|
CA2939080A1
(en)
|
2014-02-11 |
2015-08-20 |
Genzyme Corporation |
Assays for detecting the presence or amount of an anti-drug antibody
|
|
CN110894240B
(zh)
|
2014-11-26 |
2022-04-15 |
森科股份有限公司 |
结合cd3和肿瘤抗原的异二聚体抗体
|
|
EP3602056A1
(en)
|
2017-03-31 |
2020-02-05 |
Ablynx N.V. |
Improved immunogenicity assays
|
|
SG11202000025SA
(en)
*
|
2017-07-14 |
2020-02-27 |
Immatics Biotechnologies Gmbh |
Improved dual specificity polypeptide molecule
|
|
RU2020135920A
(ru)
|
2018-04-05 |
2022-05-05 |
Новартис Аг |
Триспецифические связывающие молекулы против форм рака и пути их применения
|
|
CN118852456A
(zh)
*
|
2019-05-29 |
2024-10-29 |
Cue生物制药股份有限公司 |
多聚体t细胞调节多肽及其使用方法
|
|
EP4025908A4
(en)
|
2019-09-05 |
2023-07-19 |
Adverum Biotechnologies, Inc. |
ANTI-DRUG ANTIBODY TEST
|
|
NL2024375B1
(en)
*
|
2019-12-04 |
2021-08-31 |
Apo T B V |
Methods and means for attracting immune effector cells to tumor cells.
|
|
KR20220113492A
(ko)
*
|
2019-12-11 |
2022-08-12 |
몰리큘라 파트너스 아게 |
변경된 표면 잔기를 갖는 설계된 안키린 반복 도메인
|
|
EP4304725A1
(en)
|
2021-03-09 |
2024-01-17 |
CDR-Life AG |
Rabbit-derived antigen binding protein nucleic acid libraries
|
|
US11912771B2
(en)
|
2021-03-09 |
2024-02-27 |
Cdr-Life Ag |
MAGE-A4 peptide-MHC antigen binding proteins
|